The role of β-arrestins in the formyl peptide receptor-like 1 internalization and signaling

被引:31
|
作者
Huet, Emilie
Boulay, Francois
Barral, Sophie
Rabiet, Marie-Josephe
机构
[1] CEA, Inst Rech Technol & Sci Vivant, Lab Biochim & Biophys Syst Integres, DSV,UMR 5092, F-38054 Grenoble 9, France
[2] CNRS, UMR 5092, F-38054 Grenoble, France
[3] Univ Grenoble 1, F-38000 Grenoble, France
关键词
chemoattractant receptor; beta-arrestin; internalization; signal transduction;
D O I
10.1016/j.cellsig.2007.05.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The N-formyl peptide receptor-like 1 (FPRL1) is a G protein-coupled receptor (GPCR) that transmits intracellular signals in response to a variety of agonists, many of them being clearly implicated in human pathology. beta-arrestins are adaptor proteins that uncouple GPCRs from G protein and regulate receptor internalization. They can also function as signal transducers through the scaffolding of signaling molecules, such as components of the extracellular signal-regulated kinase (ERK) cascade. We investigated the role of beta-arrestins in ligand-induced FPRL1 internalization and signaling. In HEK293 cells expressing FPRL1, fluorescence microscopy revealed that agonist-stimulated FPRL1 remained co-localized with beta-arrestins during endocytosis. Internalization of FPRL1, expressed in a mouse embryonic fibroblast (MEF) cell line lacking endogenous beta-arrestins, was highly compromised. This distinguishes FPRL1 from the prototypical formyl peptide receptor FPR that is efficiently internalized in the absence of beta-arrestins. In both HEK293 and MEF cells, FPRL1-mediated ERK1/2 activation was a rapid and transient event. The kinetics and extent of ERK1/2 activation were not significantly modified by beta-arrestin overexpression. The pattern of FPRL1-mediated ERK1/2 activation was similar whether cells express or not beta-arrestins. Furthermore, treatment of the FPRL1 expressing cells with pertussis toxin inhibited ERK1/2 activation in MEF and in HEK293 cells. These results led us to conclude that activation of ERK1/2 mediated by FPRL1 occurs primarily through G protein signaling. Since p-arrestin-mediated signaling has been observed essentially for receptors coupled to G proteins other than G(i), this may be a characteristic of Gi protein-coupled chemoattractant receptors. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1939 / 1948
页数:10
相关论文
共 50 条
  • [21] Serum amyloid a binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis.
    Kim, Wan-Uk
    Lee, Mi-Sook
    Ryu, Sung-Ho
    Park, Bo-Hyoung
    Hong, Ji-Hyun
    Kim, Hyun-Sook
    Choi, Jin-Jung
    Cho, Chul-Soo
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S398 - S398
  • [22] Formyl peptide receptor-like 1-mediated endogenous TRAIL gene expression with tumoricidal activity
    Lin, Chentao
    Wei, Wei
    Zhang, Jinchun
    Liu, Shilian
    Liu, Yanxin
    Zheng, Dexian
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (10) : 2618 - 2625
  • [23] Urokinase induces basophil chemotaxis through a urokinase receptor or epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2
    de Paulis, A
    Montuori, N
    Prevete, N
    Fiorentino, I
    Rossi, FW
    Visconte, V
    Rossi, G
    Marone, G
    Ragno, P
    JOURNAL OF IMMUNOLOGY, 2004, 173 (09): : 5739 - 5748
  • [24] Serum amyloid a induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes
    Lee, Ha Young
    Kim, Sang Doo
    Shim, Jae Woong
    Lee, Sun Young
    Lee, Hwahyung
    Cho, Kyung-Hyun
    Yun, Jeanho
    Bae, Yoe-Sik
    JOURNAL OF IMMUNOLOGY, 2008, 181 (06): : 4332 - 4339
  • [25] A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects
    Hecht, Iris
    Rong, Jiang
    Sampaio, Andre L. F.
    Hermesh, Chen
    Rutledge, Caleb
    Shemesh, Ronen
    Toporik, Amir
    Beiman, Merav
    Dassa, Liat
    Niv, Hagit
    Cojocaru, Gady
    Zauberman, Arie
    Rotman, Galit
    Perretti, Mauro
    Vinten-Johansen, Jakob
    Cohen, Yossi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (02): : 426 - 434
  • [26] Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1
    Kim, Youndong
    Lee, Byoung Dae
    Kim, Oekyung
    Bae, Yoe-Sik
    Lee, Taehoon
    Suh, Pann-Ghill
    Ryu, Sung Ho
    JOURNAL OF IMMUNOLOGY, 2006, 176 (05): : 2969 - 2975
  • [27] Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages
    Yang, D
    Chen, Q
    Le, YY
    Wang, JM
    Oppenheim, JJ
    JOURNAL OF IMMUNOLOGY, 2001, 166 (06): : 4092 - 4098
  • [28] Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1
    Wan, H-X
    Zhou, C.
    Zhang, Y.
    Sun, M.
    Wan, X.
    Yu, H.
    Yang, X.
    Ye, R. D.
    Shen, J-K
    Wang, Ming-Wei
    INFLAMMATION RESEARCH, 2007, 56 : S476 - S476
  • [29] Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor α production
    Schepetkin, Igor A.
    Kirpotina, Liliya N.
    Tian, Jun
    Khlebnikov, Andrei I.
    Ye, Richard D.
    Quinn, Mark T.
    MOLECULAR PHARMACOLOGY, 2008, 74 (02) : 392 - 402
  • [30] Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1
    Wan, Hui-Xin
    Zhou, Caihong
    Zhang, Yueyun
    Sun, Meiling
    Wang, Xin
    Yu, Hong
    Yang, Xiaoke
    Ye, Richard D.
    Shen, Jing Kang
    Wang, Ming-Wei
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (02) : 317 - 326